Bioceres (NASDAQ: BIOX ) released 1Q25 results, with challenging topline and earnings results as a result of a slow beginning to the Argentinian campaign, which may be recovered in Q2. This affected the crop nutrition (beaded fertilizers) segment, with crop protection and seeds also posting negative toplineLong-only investment, evaluating companies from an operational, buy-and-hold perspective.Quipus Capital does not focus on market-driven dynamics and future price action. Instead, our articles focus on ope ...